Global epidemiology of haemoglobin disorders and derived service indicators.
By B. Modell, Matthew W. Darlison. Bulletin of the World Health Organization, 2008
1,807 citations recorded by the source corpus.
To demonstrate a method for using genetic epidemiological data to assess the needs for equitable and cost-effective services for the treatment and prevention of haemoglobin disorders. We obtained data on demographics and prevalence of gene variants responsible for haemoglobin disorders from online databases, reference resources, and published articles. A global epidemiological database for haemoglobin disorders by country was established, including five practical service indicators to express the needs for care (indicator 1) and prevention (indicators 2-5). Haemoglobin disorders present a significant health problem in 71% of 229 countries, and these 71% of countries include 89% of all births worldwide. Over 330,000 affected infants are born annually (83% sickle cell disorders, 17% thalassaemias). Haemoglobin disorders account for about 3.4% of deaths in children less than 5 years of age. Globally, around 7% of pregnant women carry b or a zero thalassaemia, or haemoglobin S, C, D Punjab or E, and over 1% of couples are at risk. Carriers and at-risk couples should be informed of their risk and the options for reducing it. Screening for haemoglobin disorders should form part of basic health services in most countries.
Subfields: Genetics, Hematology, Pediatrics, Perinatology and Child Health
View Paper: https://www.semanticscholar.org/paper/0859d04ffe466bb7ee3da8fcc2724097b0a76ac8
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Genetics
In Hematology
In Pediatrics, Perinatology and Child Health
Citations in the corpus
- Global Burden of Sickle Cell Anaemia in Children under Five, 2010–2050: Modelling Based on Demographics, Excess Mortality, and Interventions (2013, background): “Although sickle cell disorders include not only SCA but also co-inherited haemoglobin S and haemoglobin C (HbSC disease) or b-thalassaemia (HbS/bthalassaemia), the present study focuses exclusively on SCA, the most severe and most common globally, accounting for an estimated 83% of all newborns with”